Ord/Allergan PLC (NYSE:AGN) on 10/26/2018 declared a dividend of $ 0.7200 per share payable on December 14, 2018 to shareholders of record as of November 13, 2018.

Ord/Allergan PLC (NYSE:AGN) has paid dividends since 1989, has a current dividend yield of 1.60% and has increased its dividends for 0 successive years.

Ord/Allergan PLC's market cap is $ 61,198,358,760 and has a PE ratio of 0.00. The stock price closed yesterday at $ 180.29 and has a 52 week low/high of $ 142.81 and $ 197.00.

Allergan is a specialty pharmaceutical company engaged in the development, manufacturing, marketing, and distribution of brand name pharmaceutical products, medical aesthetics, biosimilar and over-the-counter pharmaceutical products. Co. has three operating segments: U.S. Specialized Therapeutics, which provides branded products within the U.S., including medical aesthetics, medical dermatology, eye care, neurosciences and urology therapeutic products; U.S. General Medicine, which includes Central Nervous System, gastrointestinal women's health, and anti-infectives products within the U.S.; and International, which provides a range of branded and aesthetics products outside of the U.S.

For more information on Ord/Allergan PLC click here.